Cargando…

Long-Term Safety Issues of iPSC-Based Cell Therapy in a Spinal Cord Injury Model: Oncogenic Transformation with Epithelial-Mesenchymal Transition

Previously, we described the safety and therapeutic potential of neurospheres (NSs) derived from a human induced pluripotent stem cell (iPSC) clone, 201B7, in a spinal cord injury (SCI) mouse model. However, several safety issues concerning iPSC-based cell therapy remain unresolved. Here, we investi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nori, Satoshi, Okada, Yohei, Nishimura, Soraya, Sasaki, Takashi, Itakura, Go, Kobayashi, Yoshiomi, Renault-Mihara, Francois, Shimizu, Atsushi, Koya, Ikuko, Yoshida, Rei, Kudoh, Jun, Koike, Masato, Uchiyama, Yasuo, Ikeda, Eiji, Toyama, Yoshiaki, Nakamura, Masaya, Okano, Hideyuki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4375796/ https://www.ncbi.nlm.nih.gov/pubmed/25684226 http://dx.doi.org/10.1016/j.stemcr.2015.01.006

Ejemplares similares

Controlling Immune Rejection Is a Fail-Safe System against Potential Tumorigenicity after Human iPSC-Derived Neural Stem Cell Transplantation
por: Itakura, Go, et al.
Publicado: (2015)

Pre-Evaluated Safe Human iPSC-Derived Neural Stem Cells Promote Functional Recovery after Spinal Cord Injury in Common Marmoset without Tumorigenicity
por: Kobayashi, Yoshiomi, et al.
Publicado: (2012)

Regenerative therapy for spinal cord injury using iPSC technology
por: Nagoshi, Narihito, et al.
Publicado: (2020)

Fail-Safe System against Potential Tumorigenicity after Transplantation of iPSC Derivatives
por: Itakura, Go, et al.
Publicado: (2017)

Time-dependent changes in the microenvironment of injured spinal cord affects the therapeutic potential of neural stem cell transplantation for spinal cord injury
por: Nishimura, Soraya, et al.
Publicado: (2013)

Pretreatment with a γ-Secretase Inhibitor Prevents Tumor-like Overgrowth in Human iPSC-Derived Transplants for Spinal Cord Injury
por: Okubo, Toshiki, et al.
Publicado: (2016)

Focal Transplantation of Human iPSC-Derived Glial-Rich Neural Progenitors Improves Lifespan of ALS Mice
por: Kondo, Takayuki, et al.
Publicado: (2014)

Grafted Human iPS Cell-Derived Oligodendrocyte Precursor Cells Contribute to Robust Remyelination of Demyelinated Axons after Spinal Cord Injury
por: Kawabata, Soya, et al.
Publicado: (2015)

LOTUS overexpression via ex vivo gene transduction further promotes recovery of motor function following human iPSC-NS/PC transplantation for contusive spinal cord injury
por: Ito, Shuhei, et al.
Publicado: (2021)

Establishment of an in vitro model for analyzing mitochondrial ultrastructure in PRKN-mutated patient iPSC-derived dopaminergic neurons
por: Yokota, Mutsumi, et al.
Publicado: (2021)

Naive-like ESRRB(+) iPSCs with the Capacity for Rapid Neural Differentiation
por: Kisa, Fumihiko, et al.
Publicado: (2017)

First-in-human clinical trial of transplantation of iPSC-derived NS/PCs in subacute complete spinal cord injury: Study protocol
por: Sugai, Keiko, et al.
Publicado: (2021)

Novel Method for Analyzing Locomotor Ability after Spinal Cord Injury in Rats: Technical Note
por: Shinozaki, Munehisa, et al.
Publicado: (2013)

Treatment with a Gamma-Secretase Inhibitor Promotes Functional Recovery in Human iPSC- Derived Transplants for Chronic Spinal Cord Injury
por: Okubo, Toshiki, et al.
Publicado: (2018)

Cell therapy for spinal cord injury by using human iPSC-derived region-specific neural progenitor cells
por: Kajikawa, Keita, et al.
Publicado: (2020)

Reduced ER-mitochondrial contact sites and mitochondrial Ca(2+) flux in PRKN-mutant patient tyrosine hydroxylase reporter iPSC lines
por: Yokota, Mutsumi, et al.
Publicado: (2023)

Mesenchymal properties of iPSC-derived neural progenitors that generate undesired grafts after transplantation
por: Isoda, Miho, et al.
Publicado: (2023)

Pathological classification of human iPSC-derived neural stem/progenitor cells towards safety assessment of transplantation therapy for CNS diseases
por: Sugai, Keiko, et al.
Publicado: (2016)

Banking on iPSC- Is it Doable and is it Worthwhile
por: Solomon, Susan, et al.
Publicado: (2014)

Roadblocks in the Path of iPSC to the Clinic
por: Garreta, Elena, et al.
Publicado: (2018)

iPSC Bioprinting: Where are We at?
por: Romanazzo, Sara, et al.
Publicado: (2019)

Maturing iPSC-Derived Cardiomyocytes
por: Tang, Bor Luen
Publicado: (2020)

iPSC for modeling neurodegenerative disorders
por: Valadez-Barba, Valeria, et al.
Publicado: (2020)

Mitochondrial dysfunction associated with increased oxidative stress and α-synuclein accumulation in PARK2 iPSC-derived neurons and postmortem brain tissue
por: Imaizumi, Yoichi, et al.
Publicado: (2012)

Rehabilitative Training Enhances Therapeutic Effect of Human iPSC-Derived Neural Stem/Progenitor Cells Transplantation in Chronic Spinal Cord Injury
por: Shibata, Takahiro, et al.
Publicado: (2023)

Beneficial compaction of spinal cord lesion by migrating astrocytes through glycogen synthase kinase-3 inhibition
por: Renault-Mihara, Francois, et al.
Publicado: (2011)

Expression of ACE2 and a viral virulence-regulating factor CCN family member 1 in human iPSC-derived neural cells: implications for COVID-19-related CNS disorders
por: Kase, Yoshitaka, et al.
Publicado: (2020)

Pro-maturational Effects of Human iPSC-Derived Cortical Astrocytes upon iPSC-Derived Cortical Neurons
por: Hedegaard, Anne, et al.
Publicado: (2020)

Modulation by DREADD reveals the therapeutic effect of human iPSC-derived neuronal activity on functional recovery after spinal cord injury
por: Kitagawa, Takahiro, et al.
Publicado: (2022)

Comparison of two protocols for the generation of iPSC-derived human astrocytes
por: Mulica, Patrycja, et al.
Publicado: (2023)

iPSC-based model of viral infection
Publicado: (2012)

Chromatin looping is needed for iPSC induction
por: Hu, Ji-Fan, et al.
Publicado: (2014)

iPSC-MSCs and islet allograft tolerance
por: Wang, Tong-Song, et al.
Publicado: (2015)

Human iPSC banking: barriers and opportunities
por: Huang, Ching-Ying, et al.
Publicado: (2019)

Application of iPSC to Modelling of Respiratory Diseases
por: Calvert, Ben A., et al.
Publicado: (2020)

The Utilisation of Hydrogels for iPSC-Cardiomyocyte Research
por: Patel, Leena, et al.
Publicado: (2023)

Functional Recovery from Neural Stem/Progenitor Cell Transplantation Combined with Treadmill Training in Mice with Chronic Spinal Cord Injury
por: Tashiro, Syoichi, et al.
Publicado: (2016)

The pathogenesis linked to coenzyme Q10 insufficiency in iPSC-derived neurons from patients with multiple-system atrophy
por: Nakamoto, Fumiko Kusunoki, et al.
Publicado: (2018)

Mimicking the Neurotrophic Factor Profile of Embryonic Spinal Cord Controls the Differentiation Potential of Spinal Progenitors into Neuronal Cells
por: Nakamura, Masaya, et al.
Publicado: (2011)

Identifying the dynamics of actin and tubulin polymerization in iPSCs and in iPSC-derived neurons
por: Magliocca, Valentina, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_s7pmibd5j2g12c9cg2g0uq9mhu